Back to Search
MADELYN SPEAKMAN, PHARMD
PHARMD
Pharmacotherapy Pharmacist
NPI: 1366915696Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
26027963A(IN)
Research & Publications (20)
Editorial comment on: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
PMID 19070420·Eur Urol·2009
8-other
Prostate-specific antigen: could it be a useful marker for bladder outlet obstruction?
PMID 18675505·Eur Urol·2008
8-other
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome.
PMID 18565239·Curr Med Res Opin·2008
2-rct
Editorial comment on: placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia.
PMID 18417272·Eur Urol·2008
8-other
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
PMID 18298470·J Sex Med·2008
6-review
Integrating partners into erectile dysfunction treatment: improving the sexual experience for the couple.
PMID 18028387·Int J Clin Pract·2008
6-review
Acute urinary retention: medical management and the identification of risk factors for prevention.
PMID 17673913·Nat Clin Pract Urol·2007
6-review
Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers.
PMID 17564591·Paediatr Perinat Epidemiol·2007
4-observational
Gland volume in the assessment of prostatic disease: does size matter?
PMID 17559563·BJU Int·2007
6-review
Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
PMID 17257446·Curr Med Res Opin·2006
8-other
Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?
PMID 16402089·Prostate Cancer Prostatic Dis·2006
8-other
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion.
PMID 15953934·Prostate Cancer Prostatic Dis·2005
8-other
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise.
PMID 16130013·Prostate Cancer Prostatic Dis·2005
8-other
An unusual presentation of genitourinary schistosomiasis in a Caucasian woman in the UK.
PMID 16638240·Ann R Coll Surg Engl·2005
5-case
Guideline for the primary care management of male lower urinary tract symptoms.
PMID 15142148·BJU Int·2004
6-review
Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction.
PMID 15527607·Br J Gen Pract·2004
3-trial
Pelvic floor exercises for treating post-micturition dribble in men with erectile dysfunction: a randomized controlled trial.
PMID 15658735·Urol Nurs·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 5 locations total
- Address
- 2990 N WAYNE ST
ANGOLA, IN 46703 - Phone
- (260) 668-1110
Locations (5)
Practice Location
2990 N WAYNE ST, ANGOLA, IN
(260) 668-1110
Practice Location
10301 State Route 37 (Maysville Road), Fort Wayne, IN
(260) 492-1310
Practice Location
4242 E DUPONT RD, FORT WAYNE, IN
(260) 279-2520
Practice Location
6309 LIMA RD, FORT WAYNE, IN
(260) 497-1010
Practice Location
5909 ILLINOIS RD, FORT WAYNE, IN
(260) 434-3910
Quick Facts
- NPI
- 1366915696
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile